High Tower Advisors, LLC Royalty Pharma PLC Transaction History

High Tower Advisors, LLC

$76.8 Billion
Q2 2025

A detailed history of High Tower Advisors, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, High Tower Advisors, LLC holds 206,114 shares of RPRX stock, worth $7.49 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

206,114

Previous 171,394 20.26%

Holding current value

$7.49 Million

Previous $5.34 Million 39.19%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$30.85 - $36.14 $1.07 Million - $1.25 Million	34,720 Added 20.26%	206,114 $7.43 Million
Q1 2025 May 12, 2025	SELL	$25.75 - $33.86 $51,937 - $68,295	-2,017 Reduced 1.16%	171,394 $5.34 Million
Q4 2024 Feb 07, 2025	SELL	$24.28 - $28.39 $222,817 - $260,535	-9,177 Reduced 5.03%	173,411 $4.42 Million
Q3 2024 Nov 14, 2024	SELL	$25.63 - $29.27 $349,183 - $398,774	-13,624 Reduced 6.94%	182,588 $5.17 Million
Q2 2024 Aug 13, 2024	SELL	$26.26 - $29.9 $740,847 - $843,538	-28,212 Reduced 12.57%	196,212 $5.17 Million
Q1 2024 May 06, 2024	BUY	$27.46 - $31.33 $1.35 Million - $1.54 Million	49,028 Added 27.95%	224,424 $6.82 Million
Q4 2023 Feb 12, 2024	SELL	$26.21 - $29.22 $1.46 Million - $1.63 Million	-55,748 Reduced 24.12%	175,396 $4.93 Million
Q3 2023 Nov 08, 2023	BUY	$26.26 - $31.38 $1.83 Million - $2.18 Million	69,527 Added 43.02%	231,144 $6.27 Million
Q2 2023 Aug 14, 2023	SELL	$29.6 - $36.56 $72,638 - $89,718	-2,454 Reduced 1.5%	161,617 $4.97 Million
Q1 2023 May 11, 2023	BUY	$32.77 - $39.4 $167,716 - $201,649	5,118 Added 3.22%	164,071 $5.91 Million
Q4 2022 Feb 08, 2023	SELL	$39.17 - $44.04 $346,576 - $389,665	-8,848 Reduced 5.27%	158,953 $6.28 Million
Q3 2022 Nov 09, 2022	BUY	$39.88 - $44.65 $31,584 - $35,362	792 Added 0.47%	167,801 $6.74 Million
Q2 2022 Aug 10, 2022	BUY	$37.53 - $44.22 $574,321 - $676,698	15,303 Added 10.09%	167,009 $7.02 Million
Q1 2022 May 12, 2022	BUY	$37.46 - $42.44 $765,307 - $867,049	20,430 Added 15.56%	151,706 $5.92 Million
Q4 2021 Feb 10, 2022	BUY	$35.17 - $42.48 $381,981 - $461,375	10,861 Added 9.02%	131,276 $5.24 Million
Q3 2021 Nov 12, 2021	BUY	$36.14 - $42.24 $72,569 - $84,817	2,008 Added 1.7%	120,415 $4.36 Million
Q2 2021 Aug 06, 2021	BUY	$39.85 - $46.63 $4.72 Million - $5.52 Million	118,407 New	118,407 $4.85 Million

Others Institutions Holding RPRX

# of Institutions

497

Shares Held

307M

Call Options Held

1.99M

Put Options Held

384K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.9B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Royalty Pharma PLC Transaction History